Percorrer por data de Publicação, começado por "2025-04-22"
A mostrar 1 - 1 de 1
Resultados por página
Opções de ordenação
- Impact of BCL-6 downregulation in the oncogenic properties of breast cancer cellsPublication . Jorge, João Miguel Dyson de Lima; Barros, Patrícia; Jordan, PeterBreast cancer (BC) incidence has risen over the past two decades, now being the second most prevalent cancer worldwide and the fourth leading cause of cancer-related deaths. Despite advancements in BC treatment, challenges like acquired resistance, recurrence, and metastasis persist. BCL-6, a transcriptional repressor, plays a controversial role in BC development. It is overexpressed in approximately half of primary tumors across all subtypes, correlating with poorer patient prognosis. Conversely, its downregulation is linked to disease progression and metastasis, highlighting the critical need for a deeper understanding of BCL-6's dual role in BC pathogenesis. This study used RNA interference to explore the impact of BCL-6 depletion on the oncogenic progression of MCF-7 cells, a low-tumorigenic estrogen receptor-alpha-positive (ERα+) cell line. While BCL-6 is known to regulate mammary cell proliferation and differentiation, its depletion did not affect MCF-7 cell proliferation or viability but significantly reduced their individual and collective migratory properties. An RNA microarray analysis identified a set of genes upregulated following BCL-6 depletion, including S100A7, previously reported to inhibit MCF-7 cell migration and invasion in ERα+ BC cells. However, our findings showed that S100A7 downregulation alone did not affect MCF-7 migration. Moreover, simultaneous depletion of BCL-6 and S100A7 failed to restore MCF-7 cell migratory behavior. Our results suggest that increased expression of BCL-6 is linked to increased cell migration but is independent of S100A7 upregulation. Further studies are required to clarify the role of BCL-6 in BC, including disease progression.